Key facts
- Gosta Labs’s last known valuation is $6.1M (Sep 2024).
- It has raised $10.0M; the latest was Seed Round ($8.7M) in Nov 2025.
- Notable investors include Aho Group, Cor Group, Jaakko Ollila, Metsola Ventures, Reaktor Innovations — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Gosta Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Gosta Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gosta Labs
Developer of an AI health assistant platform intended to offer clinical documentation. The company's software, built on large language models, listens in the background during a healthcare appointment and automatically creates a draft of the clinical note for the doctor, enabling healthcare professionals to save time and support meaningful patient interactions.
- Sector
- Business Products and Services (B2B)
- HQ
- Espoo, Finland
- Founded
- 2023
- Employees
- 23
- Website
- gostalabs.com/
- Ownership
- Privately Held (backing)
Gosta Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gosta Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gosta Labs in its N-PORT filings yet. We sweep new filings monthly.